Telephone-based cognitive screening for neurological disorders
Avanzamenti in Materia di Screening Cognitivo Telefonico
Istituto Auxologico Italiano · NCT06337578
This study is testing a new way to check cognitive function over the phone for people with chronic neurological disorders like ALS and Alzheimer's to make it easier for them to get diagnosed and treated.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 280 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Istituto Auxologico Italiano (other) |
| Locations | 1 site (Milan) |
| Trial ID | NCT06337578 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on developing and validating telephone-based cognitive screening procedures for patients with chronic neurological disorders such as Amyotrophic Lateral Sclerosis, Alzheimer's Disease, and others. The study aims to assess the clinimetric properties and usability of these screening methods, which are crucial for diagnosis and treatment planning. By utilizing telephone assessments, the study seeks to enhance accessibility and ease of use for patients, particularly in Italy where such methods have been underexplored. The research will involve patient cohorts diagnosed with the specified conditions and will evaluate their cognitive function through structured assessments.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Lewy Body Dementia, Frontotemporal Degeneration, or Cerebrovascular Disorders.
Not a fit: Patients under 18 years old or those with psychiatric conditions, serious medical issues, or uncorrected sensory deficits may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the accessibility and effectiveness of cognitive assessments for patients with neurological disorders.
How similar studies have performed: While telephone-based cognitive screening is a relatively novel approach in Italy, similar methods have shown promise in other regions, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: Patient cohorts: diagnosis of interest. NIs: not applicable Exclusion Criteria: Patient cohorts * age \<18 years; * denial of informed consent to voluntary participation and data processing; * absence of the diagnosis of interest; * absence of a de visu cognitive screening assessment carried out in the 6 months prior to recruitment; * positive history of 1) psychiatric pathologies, 2) serious and/or uncompensated general-medical conditions and 3) uncorrected visual/hearing deficits. NIs: * age \<18 years; * denial of informed consent to voluntary participation and data processing; * positive history of 1) brain disorders, 2) serious and/or uncompensated general-medical conditions and 3) uncorrected visual/hearing deficits.
Where this trial is running
Milan
- Istituto Auxologico Italiano — Milan, Italy (RECRUITING)
Study contacts
- Study coordinator: Barbara Poletti, Ph.D.
- Email: b.poletti@auxologico.it
- Phone: +390261911
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Lewy Body Dementia, Frontotemporal Degeneration, Cerebrovascular Disorders